MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028

Description

MARKET OUTLOOK

CRI’s report on the clinical trials support services market in the Middle East and Africa states that it is likely to develop with a CAGR of 7.20% during the forecast phase from 2022 to 2028. Turkey, South Africa, Saudi Arabia, the United Arab Emirates, and Rest of Middle East & Africa are evaluated in the market in this region.
Numerous different types of clinical research activities have been conducted in the United Arab Emirates in recent years. These are sponsored mainly by government-affiliated as well as private healthcare providers, and an increasing number of trials conducted in the UAE have been registered internationally. Further, academic grants, pharmaceutical sponsorships, and other endowments also account for clinical research funding in the nation.
According to the Department of Health officials, Abu Dhabi is well-positioned to become a leading destination for clinical trials, gaining the attention of leading multinational life sciences corporations due to its diverse population and strategic location. All these factors indicate an overall positive outlook for the clinical trials support services market.
Saudi Arabia conducts 15 trials per million people, compared to 341 trials per million people in the United States. Despite the large population, excellent healthcare infrastructure, and a high physician-to-patient ratio in the KSA, it still lags behind other countries with comparable economies in terms of clinical research. Saudi’s population has its own genetic characteristics. The key to attracting biotechnology and pharmaceutical companies is to concentrate on specific research areas of importance to the nation. This, in turn, would bolster the clinical trials conducted and drive the demand for support services.

COMPETITIVE OUTLOOK

Some of the acclaimed players in the clinical trials support services market include Worldwide Clinical Trials, Charles River Laboratories, WuXi AppTec, KCR, Alcura, Medpace, ICON Plc, and Advanced Clinical.

TABLE OF CONTENTS

1. MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON THE CLINICAL TRIALS SUPPORT SERVICES MARKET
2.2. KEY INSIGHTS
2.2.1. KEY PLAYERS’ PROMISING COLLABORATIONS
2.2.2. INCREASE IN SCREENING TESTS
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. KEY BUYING IMPACT ANALYSIS
2.4.1. PERFORMANCE
2.4.2. EASE OF USE
2.4.3. SECURITY
2.4.4. COST EFFECTIVENESS
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. INDUSTRY COMPONENTS
2.8. KEY MARKET STRATEGIES
2.8.1. ACQUISITIONS
2.8.2. PRODUCT LAUNCHES
2.8.3. CONTRACTS & AGREEMENTS
2.8.4. INVESTMENTS & EXPANSIONS
2.9. MARKET DRIVERS
2.9.1. NEED TO OVERCOME THE BARRIERS IN CLINICAL TRIALS
2.9.2. RISE IN TRIALS DUE TO INCREASED DISEASE INCIDENCE
2.10. MARKET CHALLENGES
2.10.1. DELAYED APPROVAL DUE TO STRINGENT REGULATORY FRAMEWORK
2.10.2. USE OF OPEN-SOURCE SOFTWARE
2.11. MARKET OPPORTUNITIES
2.11.1. INCREASING DEMAND FOR VACCINES AND PHARMACEUTICALS
2.11.2. DATA MANAGEMENT SERVICE EXPECTED TO WITNESS NOTABLE GROWTH
2.11.3. ACQUISITIONS IN THE CLINICAL TRIALS SUPPORT SERVICES MARKET
3. MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY PHASE TYPE
3.1. PHASE I
3.2. PHASE II
3.3. PHASE III
3.4. PHASE IV
4. MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY SERVICE
4.1. CLINICAL TRIAL SITE MANAGEMENT
4.2. ADMINISTRATIVE SERVICES
4.3. PATIENT RECRUITMENT MANAGEMENT
4.4. REGULATORY SERVICES
4.5. DATA MANAGEMENT
4.6. OTHER SERVICES
5. MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY SPONSOR
5.1. PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
5.2. MEDICAL DEVICE COMPANIES
5.3. OTHER SPONSORS
6. MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET – COUNTRY OUTLOOK
6.1. UNITED ARAB EMIRATES
6.2. SAUDI ARABIA
6.3. TURKEY
6.4. SOUTH AFRICA
6.5. REST OF MIDDLE EAST & AFRICA
7. COMPETITIVE LANDSCAPE
7.1. IQVIA
7.2. PAREXEL
7.3. ICON PLC
7.4. SYNEOS HEALTH
7.5. LABCORP DRUG DEVELOPMENT
7.6. CLINIPACE
7.7. KCR
7.8. CHARLES RIVER LABORATORIES
7.9. MEDPACE
7.10. ALCURA
7.11. PSI CRO
7.12. WORLDWIDE CLINICAL TRIALS
7.13. CTI CLINICAL TRIAL AND CONSULTING SERVICES INC
7.14. WUXI APPTEC
7.15. ADVANCED CLINICAL
8. RESEARCH METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE & DELIVERABLES
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY

TABLE LIST

TABLE 1: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: LIST OF COLLABORATIONS
TABLE 3: VENDOR SCORECARD
TABLE 4: LIST OF ACQUISITIONS
TABLE 5: LIST OF PRODUCT LAUNCHES
TABLE 6: LIST OF CONTRACTS & AGREEMENTS
TABLE 7: LIST OF INVESTMENTS & BUSINESS EXPANSIONS
TABLE 8: LIST OF PANDEMIC OUTBREAKS
TABLE 9: LIST OF OPEN-SOURCE SOFTWARE
TABLE 10: LAUNCH OF MEDICAL DRUGS
TABLE 11: PROMISING ACQUISITIONS IN THE MARKET
TABLE 12: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $ MILLION)
TABLE 13: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028 (IN $ MILLION)
TABLE 14: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $ MILLION)
TABLE 15: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

FIGURE LIST

FIGURE 1: KEY BUYING IMPACT ANALYSIS
FIGURE 2: MARKET ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2021 & 2028 (IN %)
FIGURE 5: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE I, 2022-2028 (IN $ MILLION)
FIGURE 6: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE II, 2022-2028 (IN $ MILLION)
FIGURE 7: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE III, 2022-2028 (IN $ MILLION)
FIGURE 8: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE IV, 2022-2028 (IN $ MILLION)
FIGURE 9: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2021 & 2028 (IN %)
FIGURE 10: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY CLINICAL TRIAL SITE MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 11: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY ADMINISTRATIVE SERVICES, 2022-2028 (IN $ MILLION)
FIGURE 12: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 13: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY REGULATORY SERVICES, 2022-2028 (IN $ MILLION)
FIGURE 14: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY DATA MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE 15: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SERVICES, 2022-2028 (IN $ MILLION)
FIGURE 16: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2021 & 2028 (IN %)
FIGURE 17: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, 2022-2028 (IN $ MILLION)
FIGURE 18: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY MEDICAL DEVICE COMPANIES, 2022-2028 (IN $ MILLION)
FIGURE 19: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SPONSORS, 2022-2028 (IN $ MILLION)
FIGURE 20: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 21: UNITED ARAB EMIRATES CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 22: SAUDI ARABIA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 23: TURKEY CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 24: SOUTH AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE 25: REST OF MIDDLE EAST & AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)